A-Z Index
Image Cart
              

 Information For:

Manufacturers

Regulator

Healthcare

Consumers

Members

Revisions to USP32–NF27, Second Supplement

Published April 2009

General Chapters  
Monographs: A–C   D–N   O–S   T–Z  

Monograph Title Monograph Section Scientific Liaison
<1> INJECTIONS PF 34(4) Pg. 1020 INGREDIENTS Desmond Hunt
<11> USP REFERENCE STANDARDS PF 34(4) Pg. 1021 USP Cloprostenol Sodium RS, USP Dextroamphetamine Related Compound A RS, USP Dextroamphetamine Related Compound B RS, USP Enrofloxacin RS, USP Enrofloxacin Related Compound Mixture RS, USP N-Ethylpiperazine RS, USP Granisetron Related Compound C RS, USP Granisetron Related Compound D RS, USP Purified Guggul Extract RS, USP Guggulsterone Z RS, USP Itraconazole RS, USP Oxaliplatin RS, USP Oxaliplatin Related Compound A RS, USP Oxaliplatin Related Compound B RS, USP Oxaliplatin Related Compound C RS, USP Oxaliplatin Related Compound D RS, USP Guanine RS., USP Silicified Microcrystalline Cellulose RS, USP Ecamsule Solution RS, USP Ecamsule Triethanolamine RS, USP Ecamsule Related Compound A RS, USP Ecamsule Related Compound B RS, USP Ecamsule Related Compound C RS, USP Ecamsule Related Compound D RS, USP Ecamsule Related Compound E RS, USP Ecamsule Related Compound F RS, USP Ecamsule Related Compound G RS, USP Ethyl Maltol RS, USP Mesna RS, USP Mesna Related Compound A RS, USP Mesna Related Compound B RS, USP Moxifloxacin Hydrochloride RS, USP Moxifloxacin Related Compound A RS, USP Behenoyl Polyoxylglycerides RS, USP Risedronate Sodium RS, USP Risedronate Related Compound A RS, USP Risedronate Related Compound B RS, USP Risedronate Related Compound C RS, USP Tramadol Hydrochloride RS, USP Tramadol Related Compound A RS Elena Gonikberg
<207> TEST FOR 1,6-ANHYDRO DERIVATIVE FOR ENOXAPARIN SODIUM PF 34(1) Pg. 143 Title, Introduction, INTRODUCTION, DEPOLYMERIZATION OF ENOXAPARIN SODIUM BY HEPARINASES AND RESULTING OLIGOSACCHARIDES, PROCEDURE, APPENDIX 1, APPENDIX 2 Anita Szajek
<467> RESIDUAL SOLVENTS PF 34(5) Pg. 1232 OTHER ANALYTICAL PROCEDURES Horacio Pappa
<621> CHROMATOGRAPHY PF 34(1) Pg. 152 Stationary Phase, Flow Rate(GC), and Flow Rate (HPLC) of the SYSTEM SUITABILITY section Horacio Pappa
<643> TOTAL ORGANIC CARBON PF 33(4) Pg. 720 Introduction, APPARATUS REQUIREMENTS, CONTAINER PREPARATION, STANDARD SOLUTION, TEST SOLUTION, OTHER CONTROL SOLUTIONS, SYSTEM SUITABILITY, PROCEDURE, GLASSWARE PREPARATION-CONTAINER PREPARATION, WATER SAMPLE Antonio Hernandez-Cardoso
<711> DISSOLUTION PF 34(5) Pg. 1243 USP REFERENCE STANDARDS <11>, APPARATUS William Brown
<785> OSMOLALITY AND OSMOLARITY PF 34(1) Pg. 157 MEASUREMENT OF OSMOLALITY Horacio Pappa
<891> THERMAL ANALYSIS PF 34(4) Pg. 1023 INTRODUCTION, TRANSITION TEMPERATUREAND MELTING POINT TEMPERATURES, DETERMINATION OF TRANSITION TEMPERATURE (MELT ONSET TEMPERATURE) AND MELTING POINT TEMPERATURE, THERMOGRAVIMETRIC ANALYSIS, HOT-STAGE MICROSCOPY, EUTECTIC IMPURITY ANALYSIS Antonio Hernandez-Cardoso
<905> UNIFORMITY OF DOSAGE UNITS PF 34(5) Pg. 1290 Introduction, CONTENT UNIFORMITY, WEIGHT VARIATION, CRITERIA William Brown
<1090> IN VIVO BIOEQUIVALENCE GUIDANCES PF 34(4) Pg. 1028 Title, Introduction, DRUG PROTOCOL CONTENTS, GENERAL GUIDANCES, BACKGROUND, BIOAVAILABILITY, BIOEQUIVALENCE, AND DISSOLUTION, DISSOLUTION AND IN VITRO PRODUCT PERFORMANCE, BIOWAIVER, APPENDIX William Brown

General Chapters  
Monographs: A–C   D–N   O–S   T–Z